The photoswitchable cannabinoid <i>azo</i> ‐ <scp>HU308</scp> enables optical control of Ca <sup>2+</sup> dynamics in <scp>INS</scp> ‐1 β‐cells via off‐target effects on <scp>TRPC</scp> channels
Intracellular Ca<sup>2+</sup> regulates insulin secretion from pancreatic β-cells and is influenced by cannabinoid signaling. However, the hydrophobicity and complex pharmacology of cannabinoid ligands prevent precision receptor targeting, limiting our understanding of their roles in modulating insulin release. Here, we use fluorescent Ca<sup>2+</sup> imaging to examine how the light-activatable CB2 receptor agonist azo-HU308 modulates Ca<sup>2+</sup> dynamics in INS-1 β-cells. UV-A photoactivation of azo-HU308 triggered robust, repeatable Ca<sup>2+</sup> transients, and pharmacological profiling revealed this effect was independent of CB2 receptor activation but was instead mediated by extracellular Ca<sup>2+</sup> influx through TRPC channels. These findings position azo-HU308 as a novel optical tool for controlling β-cell Ca<sup>2+</sup> levels and highlight a non-GPCR pathway by which synthetic cannabinoids can modulate Ca<sup>2+</sup> dynamics in excitable cells.
Authors
- Alexander E. G. Viray (ORCID: https://orcid.org/0000-0003-4816-5990)
- James A. Frank (ORCID: https://orcid.org/0000-0001-6705-2540)
Institutions
- Oregon Health & Science University (US)
- Vollum Institute (US)
Publication Details
- Journal
- FEBS Open Bio
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1002/2211-5463.70146
- Primary Topic
- Pancreatic function and diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00